Citius Oncology, Inc.
CTORNasdaqCIK 1851484HealthcareFiscal year ends Sep 30
Reports and events: 91 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2316:10 ET | 8-K | 8.01 Other events | 0001213900-26-112109 |
| 2026-09-2916:30 ET | 8-K | 5.07 Shareholder vote results | 0001213900-26-104694 |
| 2026-08-2609:00 ET | DEF 14A | Proxy statementPeriod 2026-09-29 | 0001213900-26-093757 |
| 2026-08-1416:35 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-090184 |
| 2026-08-1416:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-090182 |
| 2026-08-1208:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-088068 |
| 2026-08-0509:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-085434 |
| 2026-06-0416:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-26-065310 |
| 2026-06-0116:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-063530 |
| 2026-05-1516:44 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-057883 |
| 2026-05-1516:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-057841 |
| 2026-05-0608:55 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-052552 |
| 2026-04-2916:41 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-049347 |
| 2026-04-2817:00 ET | 8-K | 3.01 Delisting notice | 0001213900-26-048629 |
| 2026-03-3116:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-037501 |
| 2026-03-1009:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-025464 |
| 2026-03-0409:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-023440 |
| 2026-02-1308:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-015894 |
| 2026-02-1308:00 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001213900-26-015877 |
| 2025-12-2316:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-125418 |
| 2025-12-2316:20 ET | 10-K | Annual reportPeriod 2025-09-30 | 0001213900-25-125331 |
| 2025-12-1716:10 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-25-122793 |
| 2025-12-1017:29 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-120197 |
| 2025-12-0117:12 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-116764 |
| 2025-10-2716:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-102625 |
| 2025-10-2317:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-101737 |
| 2025-09-2616:30 ET | DEF 14A | Proxy statementPeriod 2025-10-27 | 0001213900-25-092369 |
| 2025-09-1917:00 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-089615 |
| 2025-09-1216:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-25-087227 |
| 2025-09-1016:45 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-086568 |
| 2025-08-1817:26 ET | 8-K | 8.01 Other events | 0001213900-25-078018 |
| 2025-08-1216:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-075014 |
| 2025-08-1216:30 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-074992 |
| 2025-07-2517:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-25-067797 |
| 2025-07-1808:01 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-065334 |
| 2025-07-1417:22 ET | S-1/A | Registration statement, amended | 0001213900-25-063793 |
| 2025-07-1408:31 ET | S-1 | Registration statement | 0001213900-25-063483 |
| 2025-06-2717:00 ET | 8-K | 8.01 Other events | 0001213900-25-059084 |
| 2025-06-1716:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-055182 |
| 2025-05-1416:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-043359 |
| 2025-05-1416:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-043363 |
| 2025-04-2516:15 ET | 8-K | 3.01 Delisting notice | 0001213900-25-035575 |
| 2025-04-0316:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-028621 |
| 2025-02-1416:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-014351 |
| 2025-02-1416:30 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001213900-25-014320 |
| 2025-02-0609:22 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-010748 |
| 2025-01-2716:30 ET | 10-K/A | Annual report, amendedPeriod 2024-09-30 | 0001213900-25-007012 |
| 2025-01-0709:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-001407 |
| 2025-01-0608:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-000953 |
| 2024-12-2717:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-113159 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:06 ET. Listed shows no prices and gives no investment advice.